Our 2024 KNOW YOUR NETs patient education conference starts at 11 am Eastern Time. Join us here: bit.ly/3xQdxEu

Coming up next on KNOW YOUR NETS: Understanding clinical trials and immunotherapy for #neuroendocrinecancer with Dr. Dan Halperin from @MDAnderson. Join here: bit.ly/3xQdxEu Dr. Daniel Halperin

Up next in KNOW YOUR NETs: Dr. Jules Derks from Maastricht University shares #neuroendocrinecancer developments happening in Europe. Join here bit.ly/3xQdxEu

Next on KNOW YOUR NETs we are discussing "Combining & Sequencing Novel Therapies in NETs" with #neuroendocrinecancer experts from UChicago Medicine. Xavier Keutgen Join here: bit.ly/3xQdxEu

What's a Tumor Board? Up next in KNOW YOUR NETs, experts from UChicago Medicine, Huntsman Cancer Institute, and University of Miami explain this collaborative process for treating #neuroendocrinecancer. Join here: bit.ly/3xQdxEu Xavier Keutgen Aman Chauhan Mark Lewis, MD, FASCO Heloisa Soares MD

Knowing what to eat and how to manage your symptoms is crucial to living well with #neuroendocrinecancer. Up next on KNOW YOUR NETs, join experts from UChicago Medicine and Huntsman Cancer Institute to understand best practices. Join here: bit.ly/3xQdxEu Heloisa Soares MD

Coming up next on KNOW YOUR NETs: Understanding what role your genes play in #neuroendocrinecancer and how fertility is affected with experts from UChicago Medicine and Intermountain Health's Dr. Mark Lewis Mark Lewis, MD, FASCO . Join here: bit.ly/3xQdxEu

Yes, you CAN thrive & live well with #neuroendocrinecancer. Up next, NETRF's Dir of Patient Education Jessica Thomas joins Dr. Simron Singh from @SunnybrookHSC to discuss thrivership & quality of life, next on KNOW YOUR NETs. Join here: bit.ly/3xQdxEu Jessica Thomas, MSW, LCSW

It's time for our KNOW YOUR NETs Live Q&A session with our panel of #neuroendocrinecancer experts. Join here: bit.ly/3xQdxEu Heloisa Soares MD Mark Lewis, MD, FASCO Anna Greene Jessica Thomas, MSW, LCSW Xavier Keutgen Aman Chauhan

Thanks for joining us! Thank you to our co-sponsor UChicago Medicine and corporate sponsors Novartis Crinetics Pharmaceuticals and RayzeBio! To support programs like KNOW YOUR NETs please donate at netrf.org/give

Calling all early-career nuclear med researchers! NET Research Foundation and the Education and Research Foundation announce the 2024 NET Nuclear Medicine Pilot Research Grant call for applications. Apply by 8/31: mierf.org/to-apply/ #neuroendocrinecancer #CancerResearch Josh Mailman

On #WorldLungCancerDay, NET Research Foundation is reaching out to those who have been diagnosed with #neuroendocrinecancer of the lung. Often overlooked and misdiagnosed. Find resources on our website, including our updated #NETWise on LungNETs: netrf.org/podcast/netwis….

@CureNETS has posted the 2024 KNOW YOUR NETs conference videos. Watch the entire program or catch up on talks you missed. If you have #neuroendocrinecancer it's vital information! youtube.com/playlist?list=… Jessica Thomas, MSW, LCSW Josh Mailman Mark Lewis, MD, FASCO SuzanneRLudlow Aman Chauhan

Learn more about NETs and NECs 101 in NET Research Foundation August Eupdate. Plus, seeking happiness despite cancer, research updates, much more. Read here: tinyurl.com/NETRF-eupdate #neuroendocrinecancer #Cancerresearch Mark Lewis, MD, FASCO Josh Mailman NET Cancer Day LACNETS

In the search for effective treatments for #neuroendocrinecancer, what seemed impossible a few years ago may now be possible. Now there are 2 #clinicaltrials for CAR T-cell therapy in NETs. Read about them and NET Research Foundation critical role in one of them here: tinyurl.com/NETRFCAR-Tupda…

We've dosed the first patient in our Phase 1/2 clinical trial of CHM CDH17, a leading CAR-T cell therapy for advanced GI cancers. The trial aims to assess safety and determine the Phase 2 dose. This marks a key milestone for the team and patients. tinyurl.com/mry8bwdz $CHM

A milestone toward a new treatment for #NETs: The FDA has accepted Exelixis’ supplemental New Drug Application for cabozantinib to expand treatment options for some NETs, with a decision expected by April 2025. Read more from NET Research Foundation tinyurl.com/NETRFcabozanti…

Great work by these teams!

THANK YOU to new Emeritus members of our Board of Scientific Advisors.Grateful for exceptional leadership by former Chairs Ramesh Shivdasani MD, PhD @DanaFarbr George Fisher MD, PhD Stanford Medicine & Daniel Chung MD MassGeneral Medicine For more: tinyurl.com/NETRFNewBOSAem…